Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026 (P50 Clinical Trial Required)

Estimated Value: $15,000,000
Open 82 days left Healthcaregrant
Sep 22, 2023
Sep 25, 2026 12:00 AM
Healthcare
grant
AI Summary
This is a funding opportunity (grant) for Specialized Programs of Research Excellence (SPOREs) in Human Cancers for the years 2024-2026. It requires a clinical trial and falls under CFDA numbers 93.121 and 93.395.
Line Items
ItemQtyUnitEst. Unit PriceEst. TotalCategory
Comprehensive Cancer Research Program (SPORE) 1 each $5,000,000.00 $5,000,000.00 Medical
Clinical Trial Implementation and Management 1 each $3,000,000.00 $3,000,000.00 Medical
Research Personnel (Scientists, Technicians, Staff) 1 each $2,000,000.00 $2,000,000.00 Professional Services
Laboratory Supplies and Reagents 1 each $1,000,000.00 $1,000,000.00 Medical
Data Management and Analysis Services 1 each $500,000.00 $500,000.00 IT Services
Equipment Maintenance and Repair 1 each $500,000.00 $500,000.00 Facilities
Patient Care Costs (Clinical Trial) 1 each $1,000,000.00 $1,000,000.00 Medical
Travel and Conference Expenses 1 each $500,000.00 $500,000.00 Transportation
Publication and Dissemination Costs 1 each $500,000.00 $500,000.00 Professional Services
Indirect Costs 1 each $2,500,000.00 $2,500,000.00 Other
Estimated Bid Value$15,000,000.00

Want the full details?

Sign up free to see the agency name, contact info, and the original bid posting link.

Sign Up Free →

Related Bids

Browse More Bids

Healthcare BidsGRANT BidsClosing Soon All Bids